Patent · US Active

DNA2 inhibitors for cancer treatment

US10173984B2 · kind B2 · utility

3Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2018
Grant dateJan 8, 2019
Priority date—
Expiry dateJan 9, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein, inter alia, are compositions and methods for inhibiting DNA2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.